The safety of ovarian stimulation in cancer patients depends on several factors, including the type and stage of cancer, as well as the patient's overall health. For instance, in hormone-sensitive cancers such as certain types of breast cancer, the use of hormonal medications may pose risks. In such cases, fertility specialists might opt for protocols that minimize estrogen exposure, such as the use of aromatase inhibitors alongside gonadotropins.
